Citation: Sa. Mousa et al., Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban, BR J PHARM, 133(3), 2001, pp. 331-336
Authors:
Copeland, RA
Marcinkeviciene, J
Haque, TS
Kopcho, LM
Jiang, WJ
Wang, K
Ecret, LD
Sizemore, C
Amsler, KA
Foster, L
Tadesse, S
Combs, AP
Stern, AM
Trainor, GL
Slee, A
Rogers, MJ
Hobbs, F
Citation: Ra. Copeland et al., Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis, J BIOL CHEM, 275(43), 2000, pp. 33373-33378
Authors:
Mousa, SA
Bozarth, JM
Forsythe, MS
Slee, A
Citation: Sa. Mousa et al., Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels, CARDIO RES, 47(4), 2000, pp. 819-826
Authors:
Marcinkeviciene, J
Rogers, MJ
Kopcho, L
Jiang, WJ
Wang, K
Murphy, DJ
Lippy, J
Link, S
Chung, TDY
Hobbs, F
Haque, T
Trainor, GL
Slee, A
Stern, AM
Copeland, RA
Citation: J. Marcinkeviciene et al., Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones, BIOCH PHARM, 60(3), 2000, pp. 339-342